28th Nov 2016 17:30
The following amendment has been made to the Notification of Major Interest in Shares announcement released on 28 November 2016 at 12:00 under RNS No 3164Q.
The chain of controlled undertakings detailed in Section 9 has been corrected.
All other details remain unchanged. The full amended text is shown below.
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES | ||||
1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached: | Futura Medical plc | |||
2 Reason for the notification (please tick the appropriate box or boxes): | ||||
An acquisition or disposal of voting rights | ||||
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached | ||||
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments | ||||
An event changing the breakdown of voting rights | X | |||
Other (please specify): | Aggregation of holdings | |||
3. Full name of person(s) subject to thenotification obligation: | R.A. Lamb | |||
4. Full name of shareholder(s) (if different from 3.): | - | |||
5. Date of the transaction and date onwhich the threshold is crossed orreached: | 22/11/16 | |||
6. Date on which issuer notified: | 28/11/16 | |||
7. Threshold(s) that is/are crossed orreached: | 8% | |||
8. Notified details: | |||||||||||||||||
A: Voting rights attached to shares | |||||||||||||||||
Class/type ofshares if possible usingthe ISIN CODE | Situation previousto the triggeringtransaction | Resulting situation after the triggering transaction | |||||||||||||||
NumberofShares | NumberofVotingRights | Numberof shares | Number of votingrights | % of voting rights | |||||||||||||
Direct | Indirect | Direct | Indirect | Direct | Indirect | ||||||||||||
Ordinary Shares
GB0033278473 | 8,779,110 | 8,779,110 | 5,330,400 | 3,448,710 | 5,330,400 | 3,448,710 | 4.44% | 2.87% | |||||||||
B: Qualifying Financial Instruments | |||||||||||||||||
Resulting situation after the triggering transaction | |||||||||||||||||
Type of financialinstrument | Expirationdate | Exercise/Conversion Period | Number of votingrights that may beacquired if theinstrument isexercised/ converted. | % of votingrights | |||||||||||||
n/a | n/a | n/a | n/a | n/a | |||||||||||||
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments | |||||||||||||||||
Resulting situation after the triggering transaction | |||||||||||||||||
Type of financialinstrument | Exercise price | Expiration date | Exercise/Conversion period | Number of voting rights instrument refers to
| % of voting rights
| ||||||||||||
Nominal | Delta | ||||||||||||||||
Total (A+B+C) | |||||||||||||||||
Number of voting rights | Percentage of voting rights | ||||||||||||||||
8,779,110 | 7.31% | ||||||||||||||||
9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: | |||
R. A Lamb | 5,330,400 | 4.44% | |
Shares held by others but connected to R. A Lamb | 3,448,710 | 2.87% | |
Proxy Voting: | |||
10. Name of the proxy holder: | n/a | ||
11. Number of voting rights proxy holder will cease to hold: | n/a | ||
12. Date on which proxy holder will cease to hold voting rights: | n/a | ||
13. Additional information: | |||
14. Contact name: | Derek Martin | ||
15. Contact telephone number: | 01483 685670 | ||
Related Shares:
Futura Medical